1 completed, 1 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow IPG7236: new trials by email Literature Review of IPG7236 trials Research Report on IPG7236
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors IPG7236, Toripalimab Injection - Advanced Solid Tumor | Phase 1 / Phase 2 | Recruiting | Nanjing Immunophage Biotech Co., Ltd | 52 | 2026-06-16 | 2026-06-29 |
| Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors IPG7236 - Safety Issues, Tolerability | Phase 1 / Phase 2 | Completed | Nanjing Immunophage Biotech Co., Ltd | 34 | 2021-11-15 | 2026-07-08 |
Nanjing Immunophage Biotech Co., Ltd (2)
China (2) · United States (1)